BioSig Technologies Inc SEC Filings

Streamex Corp. filed a Form 4 reporting an equity grant to its Chief Financial Officer. On 11/18/2025, the CFO received 60,000 shares of Streamex common stock as an acquired (A) transaction at a stated price of $0 per share under the company’s 2023 Equity Incentive Plan, described as a restricted stock award.

The award was granted based on a closing market price of $4.14 per share on the grant date and is scheduled to vest in full on the one-year anniversary of that date. Following this grant, the reporting person beneficially owned a total of 295,000 shares of Streamex common stock, held directly. No derivative securities transactions were reported.

Streamex Corp. (STEX) director Morgan Lekstrom reported an indirect open-market purchase of the company’s common stock. On 11/21/2025, a total of 7,000 shares of common stock were acquired at a price of $3.58 per share, coded as a purchase transaction. After this trade, the reporting person is shown as beneficially owning 7,000 shares.

The filing states that these shares are held indirectly through All Mine Consulting Ltd., an entity over which the reporting person has voting and dispositive control. The Form 4 is filed as a single-reporting-person filing and reflects only non-derivative equity securities, with no derivative positions reported in Table II.

Streamex Corp. (STEX) reported that a director received a grant of 125,000 shares of common stock as a restricted stock award on November 18, 2025 under the company’s 2023 Equity Incentive Plan. The award was valued using a closing share price of $4.14 on the grant date and will vest in full on the one-year anniversary of that date. Following this grant, the director beneficially owns 228,345 shares of Streamex common stock, held directly.

Streamex Corp. is asking stockholders to vote at its virtual 2025 annual meeting on December 30, 2025. The ballot includes electing two Class I directors, advisory votes on executive pay and how often that vote should occur, ratifying CBIZ CPAs P.C. as auditor, approving a major increase to the 2023 Long-Term Incentive Plan, and a proposal to allow adjournment of the meeting if needed.

The plan amendment would raise the shares of common stock authorized for issuance under the plan by 22,494,324 shares, bringing the total to 37,230,130 shares. As of the November 7, 2025 record date, there were 39,228,103 shares of common stock outstanding, 105 shares of Series C Preferred Stock, and 109,070,079 Exchangeable Shares with voting rights similar to common stock. Common, preferred, and Super Voting Preferred Stock vote together as a single class. The board recommends voting “FOR” all six proposals.

Streamex Corp. is registering 27,885,987 shares of common stock for resale by existing holders. The shares consist mainly of up to 26,556,194 shares issuable upon conversion of two $25 million senior secured convertible debentures with Yorkville, plus 1,329,793 shares issuable on conversion of Exchangeable Shares from the Streamex acquisition. Streamex itself is not selling shares in this offering and will not receive proceeds from resales, though it previously received approximately $22.2 million in net proceeds from the first debenture, allocating $12.6 million into vaulted physical gold to support a gold-linked tokenization strategy. Shares outstanding were 148,610,687 as of November 17, 2025. The company reports large cumulative losses of about $294.1 million and auditors have raised substantial doubt about its ability to continue as a going concern, while the debentures and related registrations introduce significant potential dilution and stock overhang.

Streamex Corp. reported significant governance and leadership changes. Three directors — Steven Abelman, Christopher Baer and Anthony Amato — resigned effective immediately, each stating the decision was not due to any disagreement with the company. The board appointed Kevin Gopaul as an independent Class II director and member of all key committees, with an annual cash retainer of $40,000 plus $25,000 for each committee under the current policy.

The company entered new agreements with its top leaders. Chief Executive Officer Karl Henry McPhie will receive a $225,000 base salary, a target bonus equal to 65% of salary, and, subject to stockholder approval, 100,000 fully vested shares and 900,000 restricted stock units vesting over four years, along with double-trigger severance and equity acceleration protections. Chief Financial Officer Ferdinand Groenewald will receive the same base salary, a 65% target incentive mix of cash and equity, and, subject to stockholder approval, 100,000 shares and 400,000 RSUs, with tiered severance and COBRA benefits.

Chairman Morgan Lekstrom entered a Chairman Agreement providing a $40,000 board retainer, a $99,000 chairman retainer, and 100,000 shares vesting over one year subject to stockholder approval. Separately, a charter amendment created a classified board structure with directors divided into three staggered classes, setting multi‑year terms for Lekstrom, McPhie, Gopaul and Donald Browne.

Streamex Corp. (Nasdaq: STEX) filed its Q3 report, reflecting a transformative acquisition and a materially weaker balance sheet. Total assets rose to $130.5 million, driven by $69.9 million of goodwill and $45.4 million of intangible assets from the May 28 acquisition of Streamex Exchange. Cash increased to $11.0 million, but the company posted no revenue for Q3 and the year-to-date period.

The quarter showed a net loss of $15.6 million (Q3) and $38.8 million (nine months), as operating expenses and a $10.2 million loss from remeasuring a derivative liability weighed on results. Current liabilities surged to $125.6 million, including a $115.7 million derivative liability tied to exchangeable shares issued in the acquisition, leading to a stockholders’ deficit of $(6.9) million. Management disclosed substantial doubt about continuing as a going concern due to a $111 million working capital deficit and operating cash use of $7.4 million.

As a subsequent event, on November 4, 2025 shareholders approved lifting the 19.99% cap on conversions, allowing exchangeable shares to convert into common stock and triggering reclassification of the derivative liability to equity.

Streamex Corp. (BSGM) entered a financing and issued a secured convertible debenture. On November 4, 2025, the company closed an initial tranche with a principal amount of $25,000,000, delivering approximately $24,000,000 in gross proceeds. The debenture matures on November 4, 2027 and bears 4.00% interest, increasing to 18.00% upon an event of default.

The investor may convert principal and accrued interest at the lower of a fixed price of $6.016 per share (subject to a one-time downward reset tied to post-effectiveness VWAP) or 97.0% of the lowest daily VWAP during the three trading days before conversion, with a $4.00 per-share floor. A 4.99% beneficial ownership cap applies. The company may prepay with a 10% premium, and the debenture is secured by U.S. and Canadian guarantees and security agreements.

Directors, officers, and certain shareholders agreed to 180-day lock-ups. Streamex agreed to register the resale of conversion shares under a registration rights agreement. Yorkville may purchase a second $25,000,000 debenture upon conditions and additional debentures up to $50,000,000 upon mutual agreement.

Streamex Corp. (formerly BioSig Technologies) announced that stockholders approved the Acquisition Proposal to issue approximately 109,070,079 shares of common stock and one share of Super Voting Preferred Stock under the Share Purchase Agreement dated May 23, 2025, as amended. The proposal passed with 16,386,371 votes for, 267,215 against, and 27,673 abstentions. The company stated the acquisition of Streamex Exchange Corporation has closed.

The vote occurred at a reconvened special meeting on November 4, 2025. The company also furnished an investor presentation as Exhibit 99.1 under Regulation FD, which is not deemed filed. Streamex’s common stock trades on Nasdaq under the symbol STEX.